Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma
- 31 May 1994
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 41 (1-2) , 19-29
- https://doi.org/10.1016/0165-2427(94)90054-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Polyethylene‐glycol‐modified interleukin‐2 is superior to interleukin‐2 in locoregional immunotherapy of established guinea‐pig tumorsInternational Journal of Cancer, 1992
- Intratumoral low-dose interleukin-2 induces rejection of distant solid tumourCancer Immunology, Immunotherapy, 1991
- Local interleukin-2 therapy in bovine ocular squamous cell carcinomaCancer Immunology, Immunotherapy, 1989
- Cancer immunotherapy using local interleukin 2 administrationImmunology Letters, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary reportInternational Journal of Cancer, 1984
- The epidemiology of squamous cell carcinoma of the perineal region of sheep: Abattoir and flock studiesAustralian Veterinary Journal, 1984
- THE MAJOR CAUSES FOR CONDEMNATION OF MEAT IN N.S.W.Australian Veterinary Journal, 1960